Rare diseases
Investigational molecules
Locations
Drie Eikenstraat 655, 2650 Edegem, Belgium
Research activity in acute myeloid leukemia centers on relapse prevention, post-remission disease control, and immune-based approaches using dendritic cell vaccination and WT1-targeted therapies. The sponsor also supports work in advanced and refractory solid tumors with similar antigen-directed immunotherapy strategies.
These studies reflect a strong interest in therapeutic cancer immunology and cell-based treatment concepts in difficult-to-treat malignancies.
Antwerp University Hospital runs clinical trials in conditions such as Pleural mesothelioma malignant, Multiple sclerosis, Acute myeloid leukaemia, Critical illness, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumBelgiumIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
